Get 20% lifetime commission for referring investors to digrin.com
here.
Larimar Therapeutics, Inc. ( LRMR) - Stock Earnings
LRMR Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 13, 2026, midnight | — / — | — | — / — | — |
LRMR Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -62.5 million USD | — USD |
| 2026Q1 | -29.6 million USD | — USD |
| 2026Q2 | -32.8 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
LRMR Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -36.9 million USD | — USD |
| 2024 | -80.6 million USD | — USD |
| 2025 | -165.7 million USD | — USD |
| 2026 Est. | — | — |
LRMR
Price: $4.32
52 week price:
Earnings Per Share: -2.01 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 194
Market Capitalization: 452.9 million